Interferon Regulatory Factor 5 in the Pathogenesis of Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple genetic risk factors, high levels of interferon alpha (IFN-α), and the production of autoantibodies against components of the cell nucleus. Interferon regulatory factor 5 (IRF5) is a transcription factor which ind...
Saved in:
| Main Authors: | Candace M. Cham, Kichul Ko, Timothy B. Niewold |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1155/2012/780436 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience with type I interferon inhibitor in systemic lupus erythematosus
by: Ya. A. Leineman, et al.
Published: (2022-08-01) -
Pathogenesis of Autoimmunity/Systemic Lupus Erythematosus (SLE)
by: Shunichi Shiozawa
Published: (2025-07-01) -
Gene-Expression-Guided Selection of Candidate Loci and Molecular Phenotype Analyses Enhance Genetic Discovery in Systemic Lupus Erythematosus
by: Yelena Koldobskaya, et al.
Published: (2012-01-01) -
Genetic aspects of the pathogenesis of systemic lupus erythematosus in children
by: E. M. Kuchinskaya, et al.
Published: (2020-03-01) -
Netosis in the pathogenesis of antiphospholipid syndrome and systemic lupus erythematosus
by: K. S. Nurbaeva, et al.
Published: (2021-10-01)